Long Term Follow-up on Menkes Disease Patients

NCT04337684 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Menkes Disease

Interventions

DRUG: Long Term Follow-Up

Sponsor

Sentynl Therapeutics, Inc.